Elizabeth Austen Lawson
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Elizabeth Austen Lawson sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Elizabeth Austen Lawson: 4 sponsored US clinical trials, 3 recruiting.
Elizabeth Austen Lawson sponsors 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vasopressin Deficiency, with 1 trials.
Upper-quartile sponsor footprint
Elizabeth Austen Lawson sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
NCT04789148
Identifying Oxytocin Deficiency in Adults With Pituitary Disease
NCT06460948
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
NCT05754073
Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being
NCT04472065
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Elizabeth Austen Lawson pipeline
3 recruiting of 4 indexed (75% open); 1 completed (25%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Vasopressin Deficiency (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Elizabeth Austen Lawson: open-pipeline peers nationwide
Peers matched on 4 registered trials and 75% open enrollment, not the therapeutic-area sidebar.
Elizabeth Austen Lawson sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 75% open enrollment (± trial volume)
- Acepodia Biotech · 75% recruiting · 4 trials
- American Laboratory Products Company · 75% recruiting · 4 trials
- Amryt Pharma · 75% recruiting · 4 trials
- Amydis · 75% recruiting · 4 trials
Related
What to do with this Elizabeth Austen Lawson page
4 registered trials is a research-attention snapshot, not an endorsement of Elizabeth Austen Lawson or any single study.
- 3 of Elizabeth Austen Lawson's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vasopressin Deficiency is the condition Elizabeth Austen Lawson studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vasopressin Deficiency trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Elizabeth Austen Lawson pipeline card: 4 registered trials from official public datasets.Report a data error.